Ramirez, Reysa A.

HRN: 12-27-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2024
CEFUROXIME 1.5GM (VIAL)
05/24/2024
05/24/2024
IVT
1.5g
On Call To OR
Primary LTCS For Non Reassuring Fetal Heart Tone
Waiting Final Action 
05/25/2024
CEFUROXIME 1.5GM (VIAL)
05/25/2024
06/01/2024
IVT
1.5g
Q8
S/P Primary LTCS
Waiting Final Action 
05/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/25/2024
06/01/2024
IVT
500mg
Q8 X 7 Days
S/P Primary LTCS
Waiting Final Action 
05/25/2024
CEFUROXIME 500MG (TAB)
05/25/2024
06/01/2024
PO
500 Mg
BID
S/P Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: